Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, shared a post on X:
“ACCELERATE (great name, negative trial)
Resected Gallbladder adenocarcinoma
adjuvant chemotherapy vs chemoRT
No change in outcomes between chemo (GemCis/GemOx) vs Chemo + RT
45 vs 48 patients. Important work!
CA19-9 prognostic.”